Richard Danger

Richard Danger has a diverse work experience in the field of biotechnology and medical research. Richard is currently serving as the Co-Founder & Chief Technology Advisor at BioMAdvanced Diagnostics, a biotech/medtech start-up aiming to offer companion molecular diagnostic tests and biomarkers related to the immune response of patients. Previously, Richard worked as an Associate Researcher at INSERM U1064 - ITUN from 2015 onwards. Richard also served as an Actionnaire at Time for the Planet starting from 2022. Richard's earlier roles include being a Postdoctoral Research Associate at King's College London from 2012 to 2015 and holding positions as a Postdoctoral Fellow and Engineer/PhD student at INSERM U643 where they focused on microRNA profiling in blood from renal transplanted patients. Richard started their career as an Engineer at Microarray platform - Nantes in 2005.

Richard Danger earned their Master's degree in Immunotechnology from Aix-Marseille University in 2005. Richard then pursued a PhD in Transplantation Immunology at Nantes University from 2008 to 2011. In 2019, they attended Sorbonne Université where they completed a DU.GBM degree in Génie biologique et médical with a focus on Valorisation de la recherche publique ou privée et de l’innovation biomédicale.